Sharjah Expo: Shanti Prakashana’s 4th year of participation

Bandipur, Jan 28: British adventurer Bear Grylls and superstar Rajinikanth arrived at the Bandipur Tiger Reserve and National Park in Karnataka on Tuesday for shooting a special episode of the show 'Man vs Wild'.

The actor arrived at the location dressed in comfortable sporty clothes. Donning a dark blue jacket and grey track pants, Rajinikanth was also carrying a cross-body sling bag.

Videos and photographs of Rajinikanth arriving at a helipad were shared widely on social media.

Reports say that an agreement was signed between the Karnataka Forest Department represented by the Field Director of Bandipur and Banijay Group, Seventaurus Entertainment Studio Private Ltd, Mumbai for shooting of the documentary in December 2019. The team was also allowed to do a recce from December 27th to 29th as per the agreement, a report said.

The shooting has been permitted for six hours. "Permission for the shooting has been given for Sultan Batteri highway and ranges of Mulleholle, Maddur and Kalkere ranges. They will be shooting in non-tourist zones. If permission was given for the shooting of Wild Karnataka, then this can also be permitted. Also, no tourist or regular forest patrolling activities will be affected. The shooting will be done under special forest protection and no one will be aware of the locations," a forest official was quoted as saying in another news report.

Earlier in 2019, Grylls shot an episode of the show with Prime Minister Narendra Modi.

Grylls is also back with the latest edition of his National Geographic show ‘Running Wild With Bear Grylls’, where actors such as Channing Tatum, Brie Larson, Joel McHale, Cara Delevingne, Rob Riggle, Armie Hammer and Dave Bautista take on adventurous challenges in remote wilderness.

Mangaluru, Mar 9: A person who arrived at the airport in Mangaluru from Dubai and was admitted to the isolation ward of a hospital with symptoms of coronavirus has gone missing, sources said.

The patient, who arrived on Sunday, was shifted to the district Wenlock hospital with a high fever and a few symptoms of coronavirus.

He reportedly argued with the hospital staff late in the night that he had not contracted the virus and left the hospital saying he will take treatment in a private hospital.

The hospital health officer called up the police and a high alert has been sounded in coastal districts to locate the person who has 'escaped' from the hospital.

Dakshina Kannada district health officer Sikandar Pasha had earlier said the patient will be kept under observation for 24 hours and will be discharged after routine tests.

The district health department on Monday lodged a complaint with the Mangaluru police station and investigation is on.

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”